SRRK Scholar Rock Holding Corporation - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$46,81
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$27,0752-Wochen-Tief
$61,7652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.69B
P/E (TTM)
-14.1
EPS (TTM)
$-3.31
Umsatz (TTM)
$0
Ihre Abzeichen
52W-Spanne
$27–$62
Analystenbewertung
BUY
Kursziel
$70
P/E
-14.1
ROE
-167.8%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SRRK Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$46.81
Marktkapitalisierung (MRQ)
$5.69B
P/E (TTM)
-14.1
EPS (TTM)
$-3.31
Umsatz (TTM)
$0
ROE (TTM)
-167.8%
Verschuldungsgrad (MRQ)
0.8
52W-Spanne
$27–$62
SRRK Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02018-12-31 → 2025-12-31
EPS$-3.292020-12-31 → 2025-12-31
Freier Cashflow$-301M2018-12-31 → 2025-12-31
Nettogewinnmarge·2019-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SRRK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -14.15-Jahres-Durchschnitt ≈-10.3 | ≈-10.3 | · | · | |
| K/B (MRQ) | 22.45-Jahres-Durchschnitt ≈8.7 | ≈8.7 | 11.6 | Überbewertet | |
| EV / EBITDA | -12.55-Jahres-Durchschnitt ≈-8.0 | ≈-8.0 | · | · | |
| Kurs / FCF (TTM) | -19.25-Jahres-Durchschnitt ≈-11.2 | ≈-11.2 | · | · | |
| Kurs / Cashflow (TTM) | -19.25-Jahres-Durchschnitt ≈-11.3 | ≈-11.3 | · | · | |
| EV / FCF (TTM) | -18.25-Jahres-Durchschnitt ≈-9.6 | ≈-9.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 20.75-Jahres-Durchschnitt ≈8.7 | ≈8.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SRRK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA (TTM) | -94.6%5-Jahres-Durchschnitt ≈-55.4% | ≈-55.4% | -23.8% | Schwach | |
| ROE (TTM) | -167.8%5-Jahres-Durchschnitt ≈-94.8% | ≈-94.8% | -34.6% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SRRK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.85-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.5 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 7.05-Jahres-Durchschnitt ≈7.7 | ≈7.7 | 7.3 | Geringe Liquidität | |
| Quick Ratio | 6.65-Jahres-Durchschnitt ≈7.4 | ≈7.4 | 3.1 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.85-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.5 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SRRK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-7.6%
Nächster Bericht
Nov 12, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.84 | $-0.86 | 2.0% |
| 31. März 2026 | Mai 12, 2026 | $-0.83 | $-0.82 | -1.6% |
| 31. Dezember 2025 | $-0.88 | $-0.91 | 3.1% | |
| 30. September 2025 | $-0.90 | $-0.86 | -5.2% | |
| 30. Juni 2025 | $-0.98 | $-0.68 | -44.6% | |
| 31. März 2025 | $-0.67 | $-0.67 | 0.64% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | · | $33M | $19M | $15M | $20M | $0 | |
| R&D Expense | $208M | $185M | $122M | $124M | $108M | $74M | $54M | $36M | |
| SG&A Expense | $176M | $68M | $49M | $43M | $40M | $28M | $21M | $14M | |
| Operating Expenses | $385M | $252M | $171M | $168M | $149M | $102M | $75M | $51M | |
| Operating Income | $-385M | $-252M | $-171M | $-134M | $-130M | $-87M | $-55M | $-51M | |
| Other Non-op | $-301.0K | $-85.0K | $6M | $-132.0K | $-2M | $395.0K | $4M | $1M | |
| Net Income | $-378M | $-246M | $-166M | $-135M | $-132M | $-86M | $-51M | $-49M | |
| EPS (Basic) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · | |
| EPS (Diluted) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · | |
| Shares (Basic) | 114,701,154 | 99,838,102 | 83,347,086 | 59,611,656 | 36,711,833 | 30,734,109 | · | · | |
| Shares (Diluted) | 114,701,154 | 99,838,102 | 83,347,086 | 59,611,656 | 36,711,833 | 30,734,109 | · | · | |
| EBITDA | $-385M | $-252M | $-171M | $-134M | $-130M | $-87M | $-55M | $-51M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $324M | $178M | $102M | $103M | $213M | $160M | $36M | $115M | |
| Short-term Investments | $44M | $259M | $178M | $212M | $40M | $181M | $121M | $61M | |
| Receivables | · | · | · | · | · | · | $25M | · | |
| Prepaid Expense | $18M | $14M | $8M | $13M | $12M | $3M | $3M | $2M | |
| Current Assets | $385M | $451M | $288M | $328M | $265M | $344M | $185M | $178M | |
| PP&E (Net) | $2M | $3M | $5M | $7M | $10M | $8M | $4M | $3M | |
| PP&E (Gross) | $17M | $16M | $16M | $18M | $17M | $13M | $8M | $6M | |
| Accum. Depreciation | $15M | $13M | $11M | $10M | $7M | $5M | $4M | $2M | |
| Other Non-current Assets | $3M | $3M | $4M | $2M | $2M | $1M | $98.0K | · | |
| Total Assets | $404M | $475M | $311M | $358M | $304M | $388M | $196M | $181M | |
| Accounts Payable | $10M | $10M | $3M | $4M | $4M | $3M | $1M | $3M | |
| Accrued Liabilities | $40M | $31M | $20M | $24M | $17M | $15M | $10M | $7M | |
| Short-term Debt | · | · | $1M | · | $2M | · | · | · | |
| Current Liabilities | $55M | $47M | $33M | $36M | $64M | $43M | $33M | $31M | |
| Capital Leases | $4M | $9M | $4M | $12M | $20M | $27M | $4M | · | |
| Other Non-current Liabilities | · | · | · | · | · | $5.0K | $9.0K | · | |
| Total Liabilities | $159M | $106M | $86M | $98M | $132M | $128M | $83M | $75M | |
| Long-term Debt | · | · | $51M | $51M | $52M | $26M | · | · | |
| Total Debt | $100M | $50M | $50M | $50M | $50M | $25M | · | · | |
| Common Stock | $108.0K | $94.0K | $76.0K | $52.0K | $35.0K | $34.0K | $30.0K | $26.0K | |
| Paid-in Capital | $1.55B | $1.29B | $901M | $772M | $548M | $505M | $271M | $213M | |
| Retained Earnings | $-1.30B | $-923M | $-676M | $-511M | $-376M | $-244M | $-158M | $-107M | |
| AOCI | $94.0K | $160.0K | $92.0K | $-884.0K | $-35.0K | $-2.0K | $37.0K | $-8.0K | |
| Stockholders' Equity | $245M | $369M | $225M | $260M | $172M | $261M | $113M | $107M | |
| Liabilities + Equity | $404M | $475M | $311M | $358M | $304M | $388M | $196M | $181M | |
| Shares Outstanding | 108,461,354 | 93,823,678 | 75,979,495 | 51,672,579 | 35,209,099 | 34,152,470 | 29,792,922 | 26,217,701 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $1M | $1M | $800.0K | |
| Stock-based Comp | $76M | $37M | $27M | $28M | $23M | $11M | $8M | $5M | |
| Operating Cash Flow | $-300M | $-201M | $-145M | $-133M | $-127M | $-60M | $-63M | $25M | |
| CapEx | $602.0K | $98.0K | $71.0K | $1M | $5M | $4M | $3M | $1M | |
| Investing Cash Flow | $219M | $-76M | $41M | $-172M | $134M | $-63M | $-62M | $-60M | |
| Debt Issued | $25M | · | · | · | · | · | · | · | |
| Net Debt Issued | $-852.0K | · | · | · | · | · | · | · | |
| Stock Issued | $92M | $324M | $98M | $195M | $13M | $216M | $48M | $95M | |
| Net Stock Activity | $92M | $324M | $98M | $195M | $13M | $216M | $48M | $17M | |
| Financing Cash Flow | $228M | $353M | $103M | $195M | $45M | $248M | $49M | $94M | |
| Net Change in Cash | · | $76M | $-2M | $-110M | $52M | $124M | $-76M | $59M | |
| Taxes Paid | $46.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-301M | $-201M | $-145M | $-134M | $-132M | $-64M | $-66M | $23M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -404.8% | -690.5% | -564.0% | -266.2% | · | |
| Net Margin | · | · | · | -405.2% | -700.5% | -561.5% | -248.9% | · | |
| EBITDA Margin | · | · | · | -404.8% | -690.5% | -564.0% | -266.2% | · | |
| ROA | -86.0% | -62.7% | -49.5% | -40.6% | -38.0% | -29.6% | -27.0% | -40.6% | |
| ROE | -157.9% | -110.0% | -84.4% | -48.6% | -73.4% | -53.4% | -43.5% | -47.2% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 9.6 | 8.8 | 9.0 | 4.1 | 8.1 | 5.6 | 5.7 | |
| Quick Ratio | 6.6 | 9.3 | 8.6 | 8.7 | 3.9 | 8.0 | 5.6 | 5.6 | |
| Debt / Equity | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | · | · | |
| LT Debt / Equity | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 1.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $3.93 | $2.96 | $5.04 | $4.89 | $7.64 | $3.79 | $4.07 | |
| Revenue / Share | $0.00 | · | · | $0.56 | $0.51 | · | · | · | |
| Cash Flow / Share | $-2.62 | $-2.01 | $-1.74 | $-2.23 | $-3.45 | · | · | · | |
| Cash / Share | $2.98 | $1.90 | $1.34 | $2.00 | $6.04 | $4.70 | $1.22 | $4.39 | |
| EPS (TTM) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 76.4% | 22.2% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $48M | $48M | $33M | $19M | $15M | $20M | $0 | |
| Net Income TTM | $-378M | $-246M | $-166M | $-135M | $-132M | $-86M | $-51M | $-49M | |
| Market Cap | $4.78B | $4.06B | $1.43B | $468M | $875M | $1.66B | $393M | $602M | |
| Enterprise Value | $4.51B | $3.67B | $1.20B | $202M | $672M | $1.34B | · | · | |
| P/E | -13.4 | -17.5 | -9.4 | -4.0 | -6.9 | -17.3 | · | · | |
| P/S | · | 84.6 | 29.8 | 14.1 | 46.5 | 107.6 | 19.2 | · | |
| P/B | 19.5 | 11.0 | 6.3 | 1.8 | 5.1 | 6.4 | 3.5 | 5.6 | |
| P / Tangible Book | 19.5 | 11.0 | 6.3 | 1.8 | 5.1 | 6.4 | · | · | |
| P / Cash Flow | -15.9 | -20.2 | -9.8 | -3.5 | -6.9 | -27.5 | -6.2 | 24.5 | |
| P / FCF | -15.9 | -20.2 | -9.8 | -3.5 | -6.6 | -25.8 | -5.9 | 26.1 | |
| EV / EBITDA | -11.7 | -14.6 | -7.0 | -1.5 | -5.2 | -15.4 | · | · | |
| EV / FCF | -15.0 | -18.2 | -8.2 | -1.5 | -5.1 | -20.8 | · | · | |
| EV / Revenue | · | 76.5 | 25.0 | 6.1 | 35.7 | 87.1 | · | · | |
| Earnings Yield | -7.5% | -5.7% | -10.6% | -25.0% | -14.4% | -5.8% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $58M | $52M | $47M | $50M | $62M | $49M | $50M | $49M | $42M | $43M | $35M | $30M | $27M | $30M | $30M | $33M | |
| SG&A Expense | $51M | $50M | $45M | $53M | $50M | $28M | $19M | $16M | $17M | $15M | $13M | $13M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $109M | $102M | $92M | $104M | $112M | $77M | $69M | $65M | $59M | $58M | $48M | $44M | $39M | $41M | $40M | $44M | |
| Operating Income | $-109M | $-102M | $-92M | $-104M | $-112M | $-77M | $-69M | $-65M | $-59M | $-58M | $-48M | $-44M | $-39M | $-41M | $-40M | $-44M | |
| Other Non-op | $-570.0K | $-790.0K | $-2M | $-69.0K | $-127.0K | $-44.0K | $-2M | $-38.0K | $-14.0K | $2M | $2M | $1M | $1M | $1M | $1M | $565.0K | |
| Net Income | $-110M | $-106M | $-91M | $-102M | $-110M | $-75M | $-66M | $-64M | $-59M | $-57M | $-46M | $-42M | $-38M | $-39M | $-39M | $-43M | |
| EPS (Basic) | $-0.84 | $-0.83 | $-0.74 | $-0.90 | $-0.98 | $-0.67 | $-0.62 | $-0.66 | $-0.60 | $-0.59 | $-0.50 | $-0.53 | $-0.47 | $-0.49 | $-0.44 | $-0.55 | |
| EPS (Diluted) | $-0.84 | $-0.83 | $-0.74 | $-0.90 | $-0.98 | $-0.67 | $-0.62 | $-0.66 | $-0.60 | $-0.59 | $-0.50 | $-0.53 | $-0.47 | $-0.49 | $-0.44 | $-0.55 | |
| Shares (Basic) | 130,612,734 | 127,277,144 | · | 113,729,850 | 112,703,014 | 111,838,272 | · | 97,050,637 | 96,813,116 | 95,892,601 | · | 80,606,438 | 80,117,983 | 79,610,059 | · | 79,336,161 | |
| Shares (Diluted) | 130,612,734 | 127,277,144 | · | 113,729,850 | 112,703,014 | 111,838,272 | · | 97,050,637 | 96,813,116 | 95,892,601 | · | 80,606,438 | 80,117,983 | 79,610,059 | · | 79,336,161 | |
| EBITDA | $-109M | $-102M | · | $-104M | $-112M | $-77M | · | $-65M | $-59M | $-58M | · | $-44M | $-39M | $-41M | · | $-44M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $437M | $431M | $324M | $287M | $153M | $138M | $178M | $76M | $93M | $92M | $102M | $68M | $108M | $151M | $103M | $133M | |
| Short-term Investments | $55M | $49M | $44M | $83M | $142M | $226M | $259M | $63M | $97M | $146M | $178M | $151M | $141M | $124M | $212M | $211M | |
| Prepaid Expense | $15M | $35M | $18M | $21M | $24M | $21M | $14M | $14M | $9M | $9M | $8M | $10M | $11M | $12M | $13M | $14M | |
| Current Assets | $507M | $515M | $385M | $391M | $319M | $385M | $451M | $153M | $199M | $247M | $288M | $228M | $260M | $287M | $328M | $358M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $6M | $7M | $7M | $8M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $16M | · | · | · | $16M | · | · | · | $18M | · | |
| Accum. Depreciation | · | · | $15M | · | · | · | $13M | · | · | · | $11M | · | · | · | $10M | · | |
| Other Non-current Assets | $3M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $1M | $2M | $2M | $2M | $2M | |
| Total Assets | $524M | $535M | $404M | $412M | $340M | $408M | $475M | $179M | $227M | $267M | $311M | $251M | $285M | $315M | $358M | $390M | |
| Accounts Payable | $11M | $9M | $10M | $7M | $1M | $4M | $10M | $4M | $3M | $3M | $3M | $2M | $3M | $4M | $4M | $2M | |
| Accrued Liabilities | $55M | $44M | $40M | $50M | $44M | $28M | $31M | $29M | $22M | $21M | $20M | $17M | $14M | $15M | $24M | $23M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $2M | $6M | $1M | · | · | · | · | $805.0K | |
| Current Liabilities | $72M | $60M | $55M | $62M | $50M | $38M | $47M | $39M | $33M | $38M | $33M | $27M | $24M | $26M | $36M | $34M | |
| Capital Leases | $1M | $3M | $4M | $5M | $7M | $8M | $9M | $10M | $12M | $2M | $4M | $6M | $8M | $10M | $12M | $14M | |
| Total Liabilities | $270M | $259M | $159M | $167M | $107M | $95M | $106M | $100M | $93M | $85M | $86M | $83M | $82M | $86M | $98M | $97M | |
| Total Debt | $196M | $197M | · | $100M | $50M | $50M | · | $50M | $50M | $50M | · | $50M | $50M | $50M | · | $51M | |
| Common Stock | $122.0K | $119.0K | $108.0K | $99.0K | $96.0K | $95.0K | $94.0K | $80.0K | $80.0K | $80.0K | $76.0K | $56.0K | $55.0K | $52.0K | $52.0K | $52.0K | |
| Paid-in Capital | $1.77B | $1.68B | $1.55B | $1.45B | $1.34B | $1.31B | $1.29B | $935M | $925M | $916M | $901M | $798M | $790M | $779M | $772M | $766M | |
| Retained Earnings | $-1.52B | $-1.41B | $-1.30B | $-1.21B | $-1.11B | $-997M | $-923M | $-856M | $-792M | $-733M | $-676M | $-630M | $-588M | $-550M | $-511M | $-471M | |
| AOCI | $1M | $690.0K | $94.0K | $117.0K | $58.0K | $129.0K | $160.0K | $128.0K | $-54.0K | $-50.0K | $92.0K | $-23.0K | $-63.0K | $-329.0K | $-884.0K | $-936.0K | |
| Stockholders' Equity | $254M | $276M | $245M | $245M | $233M | $312M | $369M | $79M | $134M | $183M | $225M | $168M | $203M | $229M | $260M | $293M | |
| Liabilities + Equity | $524M | $535M | $404M | $412M | $340M | $408M | $475M | $179M | $227M | $267M | $311M | $251M | $285M | $315M | $358M | $390M | |
| Shares Outstanding | 121,600,396 | 119,103,774 | 108,461,354 | 99,171,486 | 95,999,608 | 94,873,407 | 93,823,678 | 80,081,535 | 79,992,068 | 79,744,654 | 75,979,495 | 56,260,574 | 55,159,787 | 51,989,359 | 51,672,579 | 51,660,854 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $297.0K | $335.0K | $425.0K | $423.0K | $417.0K | $393.0K | $395.0K | $446.0K | $498.0K | $598.0K | $672.0K | $708.0K | $731.0K | $733.0K | $749.0K | $744.0K | |
| Stock-based Comp | $20M | $18M | $19M | $18M | $24M | $13M | $10M | $10M | $9M | $8M | $7M | $7M | $7M | $6M | $6M | $8M | |
| Operating Cash Flow | $-70M | $-82M | $-75M | $-69M | $-77M | $-79M | $-50M | $-52M | $-49M | $-50M | $-37M | $-32M | $-33M | $-43M | $-29M | $-26M | |
| CapEx | $1.0K | $68.0K | $32.0K | $84.0K | $215.0K | $271.0K | $22.0K | $31.0K | $22.0K | $23.0K | $0 | $0 | $41.0K | $30.0K | $117.0K | $27.0K | |
| Investing Cash Flow | $-6M | $-5M | $39M | $60M | $85M | $35M | $-195M | $35M | $51M | $33M | $-25M | $-8M | $-15M | $90M | $77.0K | $-146M | |
| Debt Issued | · | · | $0 | $0 | $1.0K | $25M | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $-103M | · | · | · | $-853.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $63M | $98M | $2.0K | $92M | · | · | · | · | · | · | $92M | $0 | $4M | $827.0K | $0 | $-455.0K | |
| Net Stock Activity | · | $98M | · | · | · | · | · | · | · | · | · | · | · | $827.0K | · | · | |
| Financing Cash Flow | $83M | $194M | $73M | $144M | $6M | $4M | $346M | $166.0K | $-33.0K | $7M | $97M | $280.0K | $5M | $1M | $-970.0K | $-451.0K | |
| Net Change in Cash | · | · | · | $135M | $15M | $-40M | · | $-17M | $1M | $-10M | $34M | $-40M | $-43M | $48M | $-30M | $-173M | |
| Free Cash Flow | · | $-82M | · | · | · | $-79M | · | · | · | $-50M | · | · | · | $-43M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.4% | -22.4% | · | -34.6% | -38.8% | -22.1% | · | -30.0% | -22.9% | -19.5% | · | -13.2% | -10.7% | -13.6% | · | -12.6% | |
| ROE | -45.1% | -35.9% | · | -63.1% | -60.0% | -30.2% | · | -52.2% | -34.8% | -27.6% | · | -18.4% | -14.3% | -19.7% | · | -18.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 8.6 | · | 6.3 | 6.3 | 10.3 | · | 3.9 | 6.0 | 6.6 | · | 8.5 | 10.7 | 11.0 | · | 10.6 | |
| Quick Ratio | 6.8 | 8.0 | · | 6.0 | 5.8 | 9.7 | · | 3.5 | 5.8 | 6.4 | · | 8.2 | 10.2 | 10.5 | · | 10.2 | |
| Debt / Equity | 0.8 | 0.7 | · | 0.4 | 0.2 | 0.2 | · | 0.6 | 0.4 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| LT Debt / Equity | 0.8 | 0.7 | · | 0.4 | 0.2 | 0.2 | · | 0.6 | 0.4 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.09 | $2.32 | · | $2.47 | $2.43 | $3.29 | · | $0.99 | $1.67 | $2.29 | · | $2.98 | $3.67 | $4.40 | · | $5.68 | |
| Revenue / Share | · | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.65 | · | · | · | $-0.70 | · | · | · | $-0.52 | · | · | · | $-0.54 | · | · | |
| Cash / Share | $3.59 | $3.61 | · | $2.89 | $1.59 | $1.45 | · | $0.95 | $1.17 | $1.15 | · | $1.20 | $1.96 | $2.91 | · | $2.58 | |
| EPS (TTM) | $-3.31 | $-3.45 | · | $-3.17 | $-2.93 | $-2.55 | · | $-2.35 | $-2.22 | $-2.09 | · | $-1.93 | $-1.95 | $-2.54 | · | $-2.79 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | · | · | $33M | $33M | · | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $37M | |
| Net Income TTM | $-409M | $-409M | · | $-353M | $-316M | $-264M | · | $-226M | $-204M | $-183M | · | $-159M | $-160M | $-166M | · | $-131M | |
| Market Cap | $6.69B | $5.86B | · | $3.69B | $3.40B | $3.05B | · | $641M | $666M | $1.42B | · | $399M | $416M | $416M | · | $358M | |
| Enterprise Value | $6.39B | $5.57B | · | $3.42B | $3.16B | $2.74B | · | $552M | $526M | $1.23B | · | $231M | $217M | $190M | · | $65M | |
| P/E | -16.6 | -14.2 | · | -11.7 | -12.1 | -12.6 | · | -3.4 | -3.8 | -8.5 | · | -3.7 | -3.9 | -3.1 | · | -2.5 | |
| P/S | · | · | · | · | 102.4 | 91.9 | · | 19.3 | 20.1 | 42.7 | · | 12.0 | 12.5 | 12.5 | · | 9.6 | |
| P/B | 26.4 | 21.2 | · | 15.1 | 14.6 | 9.8 | · | 8.1 | 5.0 | 7.7 | · | 2.4 | 2.1 | 1.8 | · | 1.2 | |
| P / Tangible Book | 26.4 | 21.2 | · | 15.1 | 14.6 | 9.8 | · | 8.1 | 5.0 | 7.7 | · | 2.4 | 2.1 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -71.3 | · | · | · | -38.8 | · | · | · | -28.4 | · | · | · | -9.7 | · | · | |
| EV / Revenue | · | · | · | · | 95.1 | 82.4 | · | 16.6 | 15.8 | 37.0 | · | 7.0 | 6.5 | 5.7 | · | 1.7 | |
| Earnings Yield | -6.0% | -7.0% | · | -8.5% | -8.3% | -7.9% | · | -29.3% | -26.7% | -11.8% | · | -27.2% | -25.9% | -31.8% | · | -40.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | · | · | $33M | $19M |
| Betriebsgewinnmarge % | · | · | · | -404.8% | -690.5% |
| Nettoergebnis | $-378M | $-246M | $-166M | $-135M | $-132M |
| Verwässerte EPS | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 |
| Liquiditätsgrad | 6.9 | 9.6 | 8.8 | 9.0 | 4.1 |
| Quick Ratio | 6.6 | 9.3 | 8.6 | 8.7 | 3.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-301M | $-201M | $-145M | $-134M | $-132M |
Institutionelle Eigentümer (13F) 327 Einreicher · $7.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
327
Gehaltener Wert
$7.5B
Neue Positionen
54
Geschlossene Positionen
22
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 54 (+4 vs. Vorquartal) | 22 (-12 vs. Vorquartal) | 130 (+17 vs. Vorquartal) | 83 (+3 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $989.738.234 | 17.995.241 | 13,22% | Aktien |
| Siren, L.L.C. | $526.625.715 | 9.575.013 | 7,03% | Aktien |
| BlackRock, Inc. | $522.174.620 | 9.494.084 | 6,97% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $379.370.860 | 6.897.652 | 5,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $369.989.675 | 6.727.085 | 4,94% | Aktien |
| Orbis Allan Gray Ltd | $326.344.315 | 5.933.533 | 4,36% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $262.233.400 | 4.767.880 | 3,50% | Aktien |
| STATE STREET CORP | $260.077.455 | 4.728.681 | 3,47% | Aktien |
| Redmile Group, LLC | $237.110.060 | 4.311.092 | 3,17% | Aktien |
| VANGUARD GROUP INC | $228.860.234 | 5.195.465 | 3,06% | Aktien |
| NORGES BANK | $152.345.050 | 2.769.910 | 2,03% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $151.488.554 | 2.753.787 | 2,02% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $143.393.380 | 2.607.348 | 1,92% | Aktien |
| Bellevue Group AG | $134.725.085 | 2.449.547 | 1,80% | Aktien |
| JENNISON ASSOCIATES LLC | $129.722.285 | 2.358.587 | 1,73% | Aktien |
| Hood River Capital Management LLC | $122.363.340 | 2.224.788 | 1,63% | Aktien |
| Driehaus Capital Management LLC | $121.308.990 | 2.205.618 | 1,62% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $116.126.838 | 2.111.410 | 1,55% | Aktien |
| JANUS HENDERSON GROUP PLC | $109.890.973 | 2.236.837 | 1,47% | Aktien |
| Polar Capital Holdings Plc | $103.321.900 | 1.878.580 | 1,38% | Aktien |
| Holocene Advisors, LP | $96.578.790 | 1.755.978 | 1,29% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $95.227.110 | 1.731.402 | 1,27% | Aktien |
| MORGAN STANLEY | $84.632.717 | 1.538.776 | 1,13% | Aktien |
| Woodline Partners LP | $82.525.850 | 1.500.470 | 1,10% | Aktien |
| GOLDMAN SACHS GROUP INC | $77.631.235 | 1.411.477 | 1,04% | Aktien |
| Capital World Investors | $63.822.495 | 1.160.409 | 0,85% | Aktien |
| Clearbridge Investments, LLC | $58.287.699 | 1.059.776 | 0,78% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $56.504.635 | 1.027.357 | 0,75% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $53.891.475 | 979.845 | 0,72% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $53.635.955 | 975.197 | 0,72% | Aktien |
| NORTHERN TRUST CORP | $53.601.680 | 974.576 | 0,72% | Aktien |
| BANK OF AMERICA CORP /DE/ | $53.474.135 | 972.257 | 0,71% | Aktien |
| Pictet Asset Management Holding SA | $50.106.164 | 911.075 | 0,67% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $48.983.385 | 890.607 | 0,65% | Aktien |
| FRANKLIN RESOURCES INC | $48.329.930 | 878.726 | 0,65% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $47.535.730 | 864.286 | 0,63% | Aktien |
| Integral Health Asset Management, LLC | $41.250.000 | 750.000 | 0,55% | Aktien |
| FEDERATED HERMES, INC. | $40.398.215 | 734.513 | 0,54% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $40.154.565 | 730.083 | 0,54% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $39.463.160 | 717.512 | 0,53% | Aktien |
| Rock Springs Capital Management LP | $39.349.860 | 715.452 | 0,53% | Aktien |
| Casdin Capital, LLC | $36.575.000 | 665.000 | 0,49% | Aktien |
| Nuveen, LLC | $35.846.195 | 651.749 | 0,48% | Aktien |
| LOOMIS SAYLES & CO L P | $32.783.025 | 596.055 | 0,44% | Aktien |
| Ensign Peak Advisors, Inc | $31.847.860 | 579.052 | 0,43% | Aktien |
| Eagle Health Investments LP | $30.539.960 | 555.272 | 0,41% | Aktien |
| UBS Group AG | $28.114.350 | 511.170 | 0,38% | Aktien |
| Qube Research & Technologies Ltd | $25.505.150 | 463.730 | 0,34% | Aktien |
| Fisher Asset Management, LLC | $24.169.585 | 439.447 | 0,32% | Aktien |
| MARSHALL WACE, LLP | $23.677.500 | 430.500 | 0,32% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 Einreichungen | 7. Oktober 2025 | 7,20% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 19 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David Hallal | Chief Executive Officer | 21. September 2026 G | 1.602.382 | 0 | 2 | $-3.970.701 |
| Jay T. Backstrom | CHIEF EXECUTIVE OFFICER | 10. März 2025 A | 425.561 | 0 | 0 | $0 |
| Nagesh K. Manhathappa | Interim CEO and President | 16. Juni 2022 A | 480.491 | 0 | 0 | $0 |
| Stuart A Kingsley | President and CEO | 1. Februar 2021 A | 42.000 | 0 | 0 | $0 |
| Vikas Sinha | Chief Financial Officer | 16. April 2026 S | 619.856 | 0 | 2 | $-1.231.462 |
| Edward H Myles | COO & CFO | 10. März 2025 M | 111.345 | 0 | 0 | $0 |
| Rhonda M. Chicko | Chief Financial Officer | 31. Januar 2019 A | · | 0 | 0 | $0 |
| Akshay Vaishnaw | President of R&D | 16. April 2026 S | 630.542 | 0 | 2 | $-1.479.737 |
| Keith Woods | Chief Operating Officer | 24. September 2026 G | 572.021 | 0 | 2 | $-1.221.659 |
| Elan Ezickson | COO & Head of Corp.Development | 29. Mai 2018 A | · | 0 | 0 | $0 |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 23. Februar 2026 S | 98.445 | 0 | 9 | $-8.602.966 |
| Caryn Parlavecchio | CHRO | 17. Februar 2026 S | 169.087 | 0 | 2 | $-713.967 |
| Junlin Ho | GENERAL COUNSEL | 17. Februar 2026 S | 241.545 | 0 | 2 | $-802.309 |
| Jing L. Marantz | CHIEF MEDICAL OFFICER | 17. Februar 2026 S | 126.012 | 0 | 2 | $-451.320 |
| Tracey Sacco | Chief Commercial Officer | 25. April 2025 M | 71.750 | 0 | 0 | $0 |
| Erin Moore | Interim PFO and PAO | 24. März 2025 M | 82.609 | 0 | 0 | $0 |
| Gregory John Carven | Chief Scientific Officer | 16. Juni 2022 A | 128.208 | 0 | 0 | $0 |
| Yung H. Chyung | Chief Medical Officer | 14. Februar 2022 A | 258.496 | 0 | 0 | $0 |
| Alan J. Buckler | Chief Scientific Officer | 6. Februar 2020 A | · | 0 | 0 | $0 |
| Katie Peng | Direktor | 1. Juli 2026 S | 34.301 | 0 | 5 | $-337.751 |
| Joshua Reed | Direktor | 1. Juli 2026 S | 19.518 | 0 | 2 | $-164.075 |
| Jeffrey S. Flier | Direktor | 1. Juli 2026 S | 27.856 | 0 | 3 | $-164.491 |
| Kristina Burow | Direktor | 1. Juli 2026 S | 114.657 | 0 | 2 | $-164.053 |
| Michael Gilman | Direktor | 1. Juli 2026 S | 59.511 | 0 | 3 | $-137.058 |
| Richard Brudnick | Direktor | 4. Juni 2026 A | 21.896 | 0 | 0 | $0 |
| Srinivas Akkaraju | Direktor | 4. Juni 2026 A | 27.971 | 9 | 0 | $19.988.986 |
| Amir Nashat | Direktor | 9. Mai 2024 J | 38.639 | 0 | 0 | $0 |
| Timothy A. Springer | 10%-Eigentümer | 10. Dezember 2019 G | 2.376.567 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,94% | 6.638 SH | 11. September 2026 | Täglich |
| GURU · Global X Funds | 1,09% | 14.083 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,73% | 76.534 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,72% | 7.035 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,40% | 737.768 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,39% | 8.611 SH | 1. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,38% | 988.363 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,34% | 112.682 SH | 19. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,23% | 1.785 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,21% | 1.046 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,20% | 2.857.880 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 643.358 SH | 19. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,17% | 3.180 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,17% | 53.534 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 23.797 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,06% | 1.141.089 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,06% | 224.721 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 29.351 SH | 11. September 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 79.589 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 9.027 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 35.479 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 27.219 SH | 1. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,04% | 5.311 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 7.030 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 5.664 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.428.276 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.618 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.206 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 24.696 SH | 19. August 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 29.962 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 134.626 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 3.402 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 62.011 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 3.926 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 13.116 SH | 11. September 2026 | Täglich |
SRRK Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 24 Analysten
KAUF
Median-Ziel
$71.50
+52,7%
9 37,5%
Starker Kauf
14 58,3%
Kauf
1 4,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
16 Analysten · 2026-09-29Mittelwert-Ziel $70.44 +50,5%
← Unter allen Zielen
Aktueller Preis $46.81
Tief$58.00
Mittelwert$70.44
Hoch$84.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026